Progress in research on preclinical tumorigenicity evaluation of stem cell productsJIN Zi-yi, HOU Tian-tian, ZHANG Yi-kun, HUANG Ying, GENG Xing-chao2129-2133
Research progress in immunogenicity of stem cells in vitroHOU Tian-tian, JIN Zi-yi, JIANG Hua, LI Lu-lu, HUANG Ying, WANG San-long2134-2140
Advance in potency assay for mesenchymal stromal cellsWANG Jin-mei, QIN Mei-rong, WANG Ping, WANG Bing2151-2160
Progress and registration management of clinical research of stem cells in ChinaZHANG Kai-qiang, WANG Yue, ZHONG Wei, ZHU Hua-yuan, WANG Yuan-hui, HUANG Yi-huan, JING Yuan-hao, LI Wen-wen, YE Rong, SU Yu-wen2161-2171
Advances in cardiotoxicity assessment based on hSC-CMs under CiPAZENG Yun-qian, ZHAO Qi, YANG Hao, HOU Min-bo, YANG Shu-wen, TENG Yi-yang, WANG Xi-jie2172-2179
Therapeutic effect and mechanism of hUC-MSCs in experimental autoimmune encephalomyelitis miceHUANG Ying, JIN Zi-yi, HAO Xiao-fang, HOU Tian-tian, QIN Chao, ZHANG Yi-kun, GENG Xing-chao2180-2191
General considerations and case analysis of nonclinical research of new drugsXU Yang-mei, WAN Jiang-fan, NI Sui-ying, HE Jing-long, XIE Lei, CHENG Bin2192-2198
Discussion on collecting patient experience data in patient-focused drug developmentXIAO Meng-li, ZHAO Ying-pan, QIU Pan-bo, ZHANG Hui-e, JI Jin-jin, CHENG Yu-rong, ZHAO Meng-jie, LU Fang2199-2202
Empirical study on the core competencies of clinical research coordinatorsZHANG Bang-yu, JIANG Yi-dan, ZHANG Ling2203-2208